Texas's Cancer Focus Fund will support a Phase 1/2 clinical study assessing Israeli company's flagship drug, which uses 2 proteins - 1 to mark cancer cells and 1 to weaken them
Tel Aviv-based startup uses AI to build digital models of the human immune system and diseases to speed up treatments; two firms will test out new drugs
Vocalis Health uses AI-based software to analyze voice and identify illnesses; first joint study with Mayo will focus on finding vocal signs for pulmonary hypertension
Within a decade, more than 90 percent of surgical procedures will be performed by robots and 70% of hospital visits will take place in the patient’s own home using telemedicine
The eruption of the pandemic will not only dramatically change our lifestyles and daily routines but also how we interact with our healthcare providers
Israel's PulseNmore has developed a handheld tele-ultrasound device that enables pregnant women to perform ultrasound scans at home and get remote feedback from physician
Roche jointly sets up investment program with Israeli life-sciences VC fund aMoon, with the aim to speed up the development of new diagnostic technologies from Israel
Investors in Sight Diagnostics include US's Koch Disruptive Technologies, Hong Kong-based Longliv Ventures and OurCrowd; startup hopes device will help tackle COVID-19 too
Recent comments